Prevalence of primary biliary cholangitis in the Chinese general population and its influencing factors: A systematic review
10.3969/j.issn.1001-5256.2023.02.011
- VernacularTitle:我国一般人群原发性胆汁性胆管炎患病率及其影响因素的系统综述
- Author:
Zhicheng LIU
1
;
Zilong WANG
1
;
Jiarui ZHENG
1
;
Yandi XIE
1
;
Guangjun SONG
1
;
Bo FENG
1
Author Information
1. Department of Hepatology, Peking University People's Hospital, Beijing 100044, China
- Publication Type:Original Article_Autoimmune Liver Disease
- Keywords:
Primary Biliary Cholangitis;
Epidemiology;
Prevalence
- From:
Journal of Clinical Hepatology
2023;39(2):325-332
- CountryChina
- Language:Chinese
-
Abstract:
Objective To systematically review the epidemiological studies on primary biliary cholangitis (PBC), and to investigate the prevalence rate of PBC in the Chinese general population and its influencing factors. Methods PubMed, Embase, The Cochrane Library, CNKI, and Wanfang Data were searched for articles on the epidemiology of PBC in China published up to 31th March 2022. Two researchers independently performed screening and data extraction, and then related analyses were performed. Results A total of 9 articles were included. The positive rate of AMA was 1 049.05/100 000 (ranging fr om 159.65/100 000 to 2287.40/100 000), and the prevalence rate of PBC was 123.68/100 000 (ranging from 42.70/100 000 to 276.59/100 000). The positive rate of AMA was 636.51/100 000 (ranging from 52.55/100 000 to 1 164.33/100 000) in men and 1 265.47/100 000 (ranging from 225.23/100 000 to 1 704.93/100 000) in women, with a male/female ratio of 1∶1.99 for the prevalence rate of AMA. The prevalence rate of PBC was 40.81/100 000 (ranging from 23.54/100 000 to 75.10/100 000) in men and 148.71/100 000 (ranging from 77.36/100 000 to 214.91/100 000) in women, with a male/female ratio of 1∶3.64 for the prevalence rate of PBC. Conclusion Different studies show great differences in the positive rate of AMA and the prevalence rate of PBC in the Chinese general population, which is mainly affected by sex, age, and region. The positive rate of AMA and the prevalence rate of PBC increase with age, and the patients aged ≥50 years have a significantly higher positive rate of AMA than those aged < 50 years. The positive rate of AMA is significantly higher than the prevalence rate of PBC. There are significantly more women than men in the AMA-positive population and the PBC patients, and the influence of sex on AMA is lower than that on PBC.
